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Purpose: To determine the effect of pelvic arch interference and the depth of the pelvic 
cavity, as shown on preoperative magnetic resonance imaging (MRI), on the perform-
ance of extraperitoneal laparoscopic radical prostatectomy (ELRP). 
Materials and Methods: In 115 patients, pelvic bone images were obtained at the time 
of prostate MRI before ELRP. In the reconstructed sagittal plane, we measured the true 
conjugate diameter, the obstetric conjugate diameter, the difference between the true 
and obstetric diameters, and the distance between the true conjugate and the prostate 
apex (pelvic depth). We analyzed which factors were associated with operative time 
(OT), estimated blood loss (EBL), and positive surgical margins (PSMs). 
Results: The difference between the true and obstetric conjugate diameters was 12.7±
3.7 mm, and the pelvic depth was 59.9±6.0 mm. The OT, EBL, and the rate of PSMs 
were 260.1±91.1 minutes, 633.3±524.7 ml, and 19% (22/115), respectively. According 
to multiple linear regression analysis, predictors of a higher EBL included pelvic depth 
(3.0% higher per 1 mm increase in diameter difference, p=0.01) and prostate volume 
(1.5% higher per 1 cc increase in prostate volume, p=0.002). Factors associated with 
a longer OT were pelvic depth (p=0.04), serum prostate-specific antigen (p=0.04), pros-
tate volume (p=0.02), and Gleason score (p=0.001). For PSMs, only pT2 was an in-
dependent factor. 
Conclusions: Our results suggest that the depth of the pelvic cavity and prostate volume 
may increase surgical difficulty in patients undergoing ELRP.
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INTRODUCTION
The gold standard for the surgical treatment of clinically 
organ-confined prostate cancer has traditionally been open 
radical prostatectomy (RP). With recent advances in the 
laparoscopic approach as a minimally invasive procedure 
in a wide variety of surgical fields, laparoscopic radical 
prostatectomy (LRP) has been widely performed since 1997 
[1,2]. Reported data in Western countries have shown that 
LRP results are comparable to those of open RP in terms 
of operative parameters, morbidity, urinary function, sex-
ual function, and oncologic outcome [3-6]. Two main surgi-
cal approaches are used for RP in everyday urologic practice 
(transperitoneal and extraperitoneal). Extraperitoneal 
LRP (ELRP) allows direct access to the retropubic space, 
avoiding potential bowel injury, and it represents the tech-
nique that best replicates standard RP. Erdogru et al re-
ported that there was no statistical difference in mean oper-
ative time (OT), complication rates, or positive surgical 
margins (PSMs) between the transperitoneal and ex-
traperitoneal approaches [7]. 
　To date, several studies have identified factors predic-Korean J Urol 2011;52:39-43
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FIG. 1. Reconstructive sagittal image by Magnetom
Ⓡ in prostate
magnetic resonance imaging (MRI). 
a: true conjugate (A). 
b: 
obstetric conjugate (B). 
c: the closest distance between the true 
conjugate and the apex of the prostate (pelvic depth, C).
TABLE 1. Patient characteristics
Mean±SD
Mean age (yr) 64.2±6.2 
A
a-B
b (mm) 12.7±3.7 
C
c (mm) 59.9±6.0 
BMI (kg/m
2) 24.1±2.4 
Mean serum PSA (ng/ml) 14.7±21.2
Prostate volume
d (cc) 36.5±18.7
Pathologic Gleason score (No. of patients)
　≤6 (%) 29 (25)
　7 (%) 64 (56)
　≥8 (%) 22 (19)
Pathologic stage (No. of patients)
　T1 (%) 3 (2)
　T2 (%) 78 (68)
　T3 (%) 33 (29)
　T4 (%) 1 (1)
Operative time (minutes) 260.1±91.1 
Estimated blood loss (ml) 633.3±524.7
Positive surgical margins (No. of patients) 22 
SD: standard deviation, BMI: body mass index, PSA: prostate- 
specific antigen, 
a: true conjugate (A), 
b: obstetric conjugate (B),
c: the closest distance between the true conjugate and the apex of
the prostate (pelvic depth, C), 
d: measured by transrectal ultra-
sonography
ting the surgical outcome of patients with clinically lo-
calized prostate cancer who underwent open RP. Patient- 
related factors, such as obesity and prostate volume, have 
significant effects on the performance of open RP and ro-
bot-assisted laparoscopic radical prostatectomy (RALP) 
[8-13]. Direct access to the prostate during open surgery is 
limited by the overlying pubic bone. This anatomical chal-
lenge includes a deeper and possibly narrowed true pelvis, 
combined with occasional exostosis of the pubic symphysis. 
Although these challenges may hinder the surgeon’s abil-
ity to operate efficiently and accurately within the laparo-
scopic field, LRP has potential advantages, such as magni-
fied vision and reduced blood loss, that allow more precise 
dissection and reconstruction compared with open RP. 
Thus, we determined the effect of pelvic shape and pelvic 
arch interference, as shown on preoperative prostate mag-
netic resonance imaging (MRI), on the OT, estimated blood 
loss (EBL), and PSMs in patients who underwent ELRP. 
MATERIALS AND METHODS 
1. Patients 
The study population consisted of 115 consecutive patients 
who underwent surgery performed by one surgeon be-
tween March 2006 and May 2009. We investigated various 
clinicopathologic variables, including age, body mass in-
dex (BMI), preoperative prostate-specific antigen (PSA) 
level, prostate volume (as measured by transrectal ultra-
sonography [TRUS]), pathologic stage, pathologic Gleason 
score, OT, EBL, and surgical margin status. 
2. Estimated pelvimetry 
On the basis of the preoperative prostate MRI performed 
on a 3.0-T MR system (Magnetom Tim Trio; SIEMENS, 
Erlangen, Germany) with an 8-channel body coil, various 
bony pelvic dimensions likely to reflect the pelvic inlet di-
ameter or depth were measured as follows (Fig. 1): the true 
conjugate diameter (the distance from the most superior 
aspect of the pubic symphysis to the sacral promontory) as 
measured on a midsagittal image from the MRI, the ob-
stetric conjugate diameter (the closest distance from the 
pubic symphysis to the sacral promontory), and the differ-
ence between the true conjugate and the obstetric conju-
gate. This difference was intended to evaluate the extent 
of protrusion of the pubic symphysis. To assess the pelvic 
depth, we designated a new parameter, defined as the clos-
est distance from the true conjugate to the apex of the pros-
tate (pelvic depth), as measured on the midsagittal image 
from the MRI (Fig. 1). 
3. Statistical analysis 
Multiple linear and logistic regression analyses were used 
to identify associative factors for OT, EBL, and PSMs. All 
analyses were performed by using the SPSS ver 12.0 (SPSS 
Inc., Chicago, IL, USA). The results were considered stat-
istically significant when the p-value was ＜0.05. 
RESULTS
1. Patient characteristics 
The mean patient age was 64.2±6.2 years, and the patients’ 
mean BMI was 24.1±2.4 kg/m
2. The mean preoperative se-
rum PSA level was 14.7±21.2 ng/ml, and the mean prostate 
volume was 36.5±18.7 cc (Table 1). Korean J Urol 2011;52:39-43
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TABLE 2. Multiple linear regression analysis of factors affecting 
estimated blood loss
Variables Beta
Standard 
error
p-value
A
a-B
b (mm)    6.26   12.67 0.622
C
c (mm)    19.53     7.45 0.01 
Age (yr) −13.37     7.39 0.074
BMI (kg/m
2) −1.19   19.35 0.951
Mean serum PSA (ng/ml)    3.25     2.21 0.145
Prostate volume
d (cc)    9.64     2.99 0.002
Pathologic Gleason score
e
　7 −114.31 116.82 0.33 
　≥8   38.71 145.49 0.791
Pathologic stage
f
　T2   42.19 103.23 0.684
BMI: body mass index, PSA: prostate-specific antigen, 
a: true con-
jugate (A), 
b: obstetric conjugate (B), 
c: the closest distance between 
the true conjugate and the apex of the prostate (pelvic depth, C),
d: measured by transrectal ultrasonography, 
e: pathologic Gleason
score ≤6 as a reference, 
f: pathologic stage (T3, T4) as a reference
TABLE 3. Multiple linear regression analysis of factors affecting 
operative time 
Variables Beta
Standard 
error
p-value
A
a-B
b (mm) −1.09   2.28 0.634
C
c (mm) 　2.76   1.34 0.042
Age (yr) −0.71   1.33 0.593
BMI (kg/m
2) 　2.04   3.49 0.56
Mean serum PSA (ng/ml) 　0.82   0.40 0.042
Prostate volume
d (cc) 　1.24   0.64 0.024
Pathologic Gleason score
e
　7 23.54 21.06 0.266
　≥8 87.11 26.23 0.001
Pathologic stage
f
　T2 3.1 18.61 0.868
BMI: body mass index, PSA: prostate-specific antigen, 
a: true con-
jugate (A), 
b: obstetric conjugate (B), 
c: the closest distance between 
the true conjugate and the apex of the prostate (pelvic depth, C),
d: measured by transrectal ultrasonography, 
e: pathologic Gleason
score ≤6 as a reference, 
f: pathologic stage (T3, T4) as a reference
TABLE 4. Multiple logistic regression analysis of factors affecting
positive surgical margins 
Variables Odds ratio (95% CI) p-value
A
a-B
b (mm) 1.02 (0.89-1.18) 0.747
C
c (mm) 1.01 (0.93-1.09) 0.848
Age (yr) 0.98 (0.90-1.06) 0.626
BMI (kg/m
2) 0.85 (0.68-1.08) 0.186
Mean serum PSA (ng/ml) 1.00 (0.97-1.02) 0.793
Prostate volume
d (cc) 1.00 (0.97-1.03) 0.974
Pathologic Gleason score
e
　7 0.76 (0.18-3.20) 0.706
　≥8 0.98 (0.18-5.26) 0.983
Pathologic stage
f
　T2   3.86 (1.28-11.70) 0.017
BMI: body mass index, PSA: prostate-specific antigen, 
a: true con-
jugate (A), 
b: obstetric conjugate (B), 
c: the closest distance between 
the true conjugate and the apex of the prostate (pelvic depth, C),
d: measured by transrectal ultrasonography, 
e: pathologic Gleason
score ≤6 as a reference, 
f: pathologic stage (T3, T4) as a reference
2. MRI pelvimetry 
The mean bony pelvic dimensions, as assessed on MRI, 
were as follows: true conjugate diameter, 112.1±10.7 mm; 
obstetric conjugate diameter, 99.3±7.2 mm; and the differ-
ence between the true conjugate diameter and the obstetric 
conjugate diameter, 12.7±3.7 mm. For the newly developed 
parameter of pelvic depth, the mean was 59.9±6.0 mm 
(Table 1). 
3. Surgical outcomes 
The OT was 260.1±91.1 minutes. The EBL was 633.3±524.7 
ml. The PSM rate was 19%. The overall pathologic results 
showed clinically localized disease (pT2) in 68% of the pa-
tients and extraprostatic disease (pT3 or pT4) in 30% of the 
patients. The percentage of men with a pathologic Gleason 
score of ≤6, 7, and ≥8 was 25%, 56%, and 19%, respectively 
(Table 1). 
4. Factors affecting OT, EBL, and PSMs 
According to the multiple linear regression analysis, the 
prostate volume and pelvic depth were independent pre-
dictive factors for EBL (p=0.01 and p=0.01, respectively) 
(Table 2). The EBL rate was increased 3% (19.5/633.3x100) 
and 1.5% (9.6/633.3x100) as the pelvic depth was 1 mm dee-
per and the prostate was 1 cc larger, respectively. Factors 
that were correlated with a longer OT included the serum 
PSA, prostate volume, pelvic depth, and a Gleason score ≥8 
(p=0.04, p=0.02, p=0.04, and p=0.001, respectively) (Table 
3). According to the multiple logistic regression analysis, 
only pT2 was an independent factor of PSMs (adjusted odds 
ratio [OR], 3.9; 95% confidence interval [CI], 1.3-11.7; 
p=0.02) (Table 4). 
DISCUSSION
It was recently reported that the oncologic results of ELRP 
are similar to those of open RP and transperitoneal LRP 
(TLRP) [14-16]. However, LRP is a difficult procedure that 
requires surgical skill and has a flat learning curve [4,17]. 
The outcomes of LRP depend on several factors, including 
surgical skill and the experience of the surgeon and the sur-
gical team. In addition to the technical difficulties of the 
surgery, the body habitus of the patients can sometimes be 
an obstacle to any RP. Specifically, because an apical dis-
section is expected to be more challenging with a prostate 
situated deep in a narrow pelvis, and the technical chal-Korean J Urol 2011;52:39-43
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lenges of an apical dissection are potentially more easily 
overcome with LRP than open RP, we sought to determine 
the effect of pelvic arch interference and the depth of the 
pelvic cavity on operative outcomes of LRP. 
　Several researchers have reported that obesity can make 
open RP more technically difficult. Chang et al identified 
BMI as a predictor of blood loss and transfusion during 
open RP [9]. Brown et al noted that there is a trend toward 
a longer OT in obese men undergoing LRP [18]. Even for 
RALP, Ahlering et al revealed that BMI significantly af-
fects the OT and EBL [12]. Moreover, Castle et al reported 
a significantly higher rate of PSM and a significantly longer 
OT and increased EBL in obese patients who underwent 
RALP [19]. However, our results suggest that obesity does 
not have a significant effect on the results of LRP when the 
procedure is performed by an experienced surgeon. 
　Along with obesity, a large prostate is usually accom-
panied by increased vascularity and has been acknowl-
edged by some surgeons as having significant effects on 
open RP or LRP. Hsu et al reported a direct correlation be-
tween blood loss, transfusion requirements, and prostate 
volume during open RP [8]. Patients with larger prostates 
had a transfusion rate 2.5 times that of patients with small-
er prostates. Rassweiler et al noted a direct correlation be-
tween blood transfusion and prostate size during LRP; 17% 
of patients with a prostate ＜25 cc required transfusions 
compared with 47% of patients with prostates ＞45 cc [20]. 
Also, larger prostate volumes have been reported to be cor-
related with increased OT in most LRP studies [20-22]. 
Additionally, in several open or minimally invasive RP ser-
ies, prostate volume was reported to have an inverse rela-
tionship with PSM rates [8,21]. In the current study, pros-
tate volume was an independent predictor of OT and EBL, 
but not PSMs. 
　Similar to prostate volume, the dimensions of the pelvic 
inlet are an important parameter in predicting operative 
results. A large, wide pelvis allows increased operative 
movement and instruments to reach a large prostate. On 
the other hand, a deep, narrow pelvis and protrusion of the 
pubic symphysis tend to preclude the path of the laparo-
scope. Given that prediction of a difficult prostate apical 
dissection is important in reducing PSMs during LRP, it 
is necessary to have a better understanding of pelvic ana-
tomical structure. If the working instruments are dis-
placed out of the pelvis by pubic protrusion, the instru-
ments may not reach the desired points during apical dis-
section or urethrovesical anastomosis. 
　An impression of pelvic size and shape may be gained 
from the patient's height, weight, and build, but such an 
impression is subjective, inaccurate, and will vary between 
urologists. Also, relevant objective data are sparse for bony 
pelvic dimensions on RP; therefore, pelvic size is difficult 
to quantify objectively. Kim et al previously developed new 
parameters for pelvic dimensions in an open RP study [23]. 
These parameters included views on MRI pelvimetry, 
which may provide a more reliable measurement of com-
plex female pelvic floor structures than does X-ray pelvim-
etry, insights into the contribution of dystocia to obstructed 
labor in obstetric practice, and information for pre-
operative clinical staging of prostate cancer. 
　Therefore, using prostate MRI, we determined the 
amount of protrusion of the pubic symphysis from the pel-
vic cavity by applying obstetric pelvimetry and tried to ob-
jectify the pelvic depth from the pelvic inlet by using the 
distance between the pelvic inlet and the apex of the 
prostate. We determined the difference between the true 
conjugate diameter and the obstetric conjugate diameter. 
As the difference between the distances increased, the pu-
bic symphysis protruding out of the pelvic cavity became 
longer. However, the amount of protrusion of the pubic 
symphysis from the pelvic cavity did not affect the surgical 
outcome. During open RP, the protrusion of the pubic 
symphysis affects the surgical outcome by narrowing the 
operative field and making the use of surgical instruments 
difficult, whereas the penetration of the laparoscope into 
the extraperitoneal cavity inside the pelvis was not 
affected. Therefore, the ease of securing the field of vision 
and the use of long micro-tools allow the surgeon to over-
come the protrusion of the pubic symphysis. 
　Prostate volume and pelvic depth did affect the EBL and 
OT. That is, as the prostate volume increased by 1 cc, the 
EBL and OT increased by 9.6 ml and 1.2 minutes, respec-
tively, and as the distance to the prostate apex increased 
by 1 mm, the EBL and OT increased by 19.5 ml and 2.8 mi-
nutes, respectively. Also, the preoperative PSA and a 
Gleason score ≥8 were had an effect on the OT. 
　Several studies have evaluated operative difficulty by 
using permutation of pelvimetry. Hong et al used pre-
operative MRI to determine the pelvic interspinous diame-
ter (ISD), which reflects the pelvic area during open RP 
[24]. They analyzed the craniocaudal distance from the 
most proximal margin of the pubic symphysis to the distal 
margin of the apex of the prostate, designated the distance 
as apical depth (AD), and created a new parameter called 
the pelvic dimension index (PDI), which is the value of the 
ISD divided by the AD. However, this parameter does not 
affect EBL or OT [24]. Furthermore, they measured the an-
teroposterior diameter of the pelvic inlet (API; the distance 
from the most superior aspect of the pubic symphysis to the 
sacral promontory), pelvic depth (PD; the distance from the 
sacral promontory to the lower inner pubic symphysis), and 
the pelvic cavity index (PCI=API x ISD/PD) and applied it 
during RALP, but it had no effect on the operative result 
[25]. 
　Emerson et al reported that a high preoperative PSA lev-
el was related to the rate of PSMs after open RP [26]. In our 
study, only pT2 was related to the rate of PSMs. 
　This study was not without limitations, including its ret-
rospective nature, small number of cases, and consideration 
of only the preoperative factors affecting perioperative out-
comes, but not surgeon’s characteristics or surgical factors 
such as neurovascular bundle preservation, vesicourethral 
anastomosis, and pelvic lymphadenectomy. However, to 
minimize the confounding effect of surgical skill and tech-Korean J Urol 2011;52:39-43
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nique, we confined our study to a single, experienced sur-
geon. Also, we used obstetric pelvimetry, which is a more 
physiologic parameter because of the movement of the fetal 
head during delivery. These are several factors that make 
our results different from other results. 
CONCLUSIONS
The depth of the pelvic cavity and prostate volume eval-
uated by pelvic MRI are predictive factors for surgical diffi-
culty during LRP. This can be considered useful infor-
mation when planning LRP for clinically localized prostate 
cancer. However, further studies are warranted that in-
clude surgeon-related factors and surgical factors affecting 
the surgical outcome of LRP.
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